Recurring headaches may seem harmless, but experts warn they can signal serious underlying brain or vascular conditions. Here ...

Lung cancer stands as a formidable health challenge, claiming more lives globally than any other type of cancer. This ...

In a major step forward for cardiac care in the UAE, Cleveland Clinic Abu Dhabi has successfully performed the country’s ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

The weeks leading into winter are often the ideal time to address sinus issues. By improving sinus function before cold and ...

“Virginia’s humidity changes fast,” said Bane. “One day it’s damp and warm, the next it’s crisp and dry. That constant fluctuation irritates nasal passages, triggers swelling and creates the perfect ...

TARRYTOWN, N.Y. and PARIS, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the presentation of positive results from the pivotal ...

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years ...

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...

Dear Dr. Roach: At age 76, I was diagnosed with sinus node dysfunction last year after several episodes of what I’d call being “spaced out” (for lack of a better term). I couldn’t explain these ...

Recently, the U.S. Food and Drug Administration (FDA) accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent in adults and children aged 6 years and older with ...

Dear Dr. Roach: At age 76, I was diagnosed with sinus node dysfunction last year after several episodes of what I'd call being "spaced out" (for lack of a better term). I couldn't explain these ...